Exelixis Inc (NASDAQ:EXEL) shares traded -4.2% down during most recent session to reach at the closing price of $18.93. The stock exchanged hands 3.65 Million shares versus average trading capacity of 3.36 Million shares, yielding a market cap of $5.68 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $30.08 within the next 52-weeks. The mean target projections are based on 12 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Exelixis Inc (NASDAQ:EXEL) high price target of $45 and with a conservative view have low price target of $22.

“Upgrades” Exelixis Inc (NASDAQ:EXEL) in a research note issued to investors on 3/18/19 to Equal-Weight.

Additionally on 2/22/19 “Initiates Coverage On” Exelixis Inc (NASDAQ:EXEL) to Market Perform setting price target at $23 and on 9/17/18 “Initiates Coverage On” the stock to Neutral at $22. Furthermore on 9/10/18 “Initiates Coverage On” the stock to Underweight at $19.

On the other hand the company has Relative Strength Index (RSI 14) of 30.59 along with Average True Range (ATR 14) of 0.88, Consequently Exelixis Inc (NASDAQ:EXEL)’s weekly and monthly volatility is 3.55%, 4.47% respectively. The company’s beta value is at 2.07.

In terms of Buy, Sell or Hold recommendations, Exelixis Inc (NASDAQ:EXEL) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Exelixis Inc (NASDAQ:EXEL)’s minimum EPS for the current quarter is at $0.19 and can go high up to $0.31. The consensus mean EPS for the current quarter is at $0.25 derived from a total of 12 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.28 earnings per share for the same quarter during last year.

Previously Exelixis Inc (NASDAQ:EXEL) reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. The company posted an earnings surprise of 4.3%.

Exelixis Inc (NASDAQ:EXEL)’s revenue estimates for the current quarter are $229.05 Million according to 12 number of analysts, for the current quarter the company has high revenue estimates of $250.92 Million in contradiction of low revenue estimates of $204 Million. For the current year the company’s revenue estimates are $920.04 Million compared to low analyst estimates of $859 Million and high estimates of $973.79 Million according to 13 number of analysts.

Currently Exelixis Inc (NASDAQ:EXEL)’s shares owned by insiders are 1.4%, whereas shares owned by institutional owners are 78.3%. However the six-month change in the insider ownership was recorded -27.66%, as well as three-month change in the institutional ownership was recorded 1.32%.

Exelixis Inc (NASDAQ:EXEL)’s trailing twelve month revenues are $855.6 Million, whereas its price to sales ratio for the same period is 6.64. Its book value per share for the most recent quarter is $4.61 while its price to book ratio for the same period is 4.11, as for as the company’s cash per share for the most recent quarter is $2.67, however its price to cash per share ratio for the same period is 7.1. The stock has 5 year expected PEG ratio of 0.2 whereas its trailing twelve month P/E ratio is 9.09.